Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis.
Authors: Koenig C; Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, Connecticut, USA.; Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Monogue ML; The University of Texas Southwestern Medical Center, Dallas, Texas, USA., Shields RK; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Sakon CM; Indiana University Health, Indianapolis, Indiana, USA., Fratoni AJ; Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, Connecticut, USA., Roenfanz HF; Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, Connecticut, USA., Finklea JD; The University of Texas Southwestern Medical Center, Dallas, Texas, USA., Pope JS; Division of Pulmonary and Critical Care Medicine, Hartford Hospital, Hartford, Connecticut, USA., Nicolau DP; Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, Connecticut, USA.; Division of Infectious Diseases, Hartford Hospital, Hartford, Connecticut, USA., Kuti JL; Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, Connecticut, USA.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Jan 31; Vol. 69 (1), pp. e0153924. Date of Electronic Publication: 2024 Dec 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.01539-24